Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack

NCT07236333 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT07236333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07236333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack
Lead sponsor
Ataturk University
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
March 31, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)